Horizon Therapeutics plc to Present at the Cowen and Company 40th Annual Health Care Conference

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in March:

Cowen and Company 40th Annual Health Care Conference

• Date: Tuesday, Mar. 3, 2020
• Presentation Time: 12 p.m. ET
• Location: Boston

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for the event.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200218005262/en/

Investors:
Tina Ventura
Senior Vice President,
Investor Relations
[email protected]

Ruth Venning
Executive Director,
Investor Relations
[email protected]

U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer
[email protected]

Ireland Media:
Ray Gordon
Gordon MRM
[email protected]

Source: Horizon Therapeutics plc

You May Also Be Interested In

• Bilateral Chamber Hosts Iraqi Prime Minister and his Delegation in Houston
• Angel Oak Capital Completes Fourth Securitization of 2024, Fueled by Rapid Growth of Mortgage Solutions Origination Platform
• American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes